Projections of the Cost of Cancer Care in the United States: 2010-2020
Angela B. Mariotto, K. Robin Yabroff, Yu‐Hsuan Joni Shao, E. J. Feuer, Martin L. Brown
JNCI Journal of the National Cancer Institute
Abstract
BACKGROUND: Current estimates of the costs of cancer care in the United States are based on data from 2003 and earlier. However, incidence, survival, and practice patterns have been changing for the majority of cancers. METHODS: Cancer prevalence was estimated and projected by phase of care (initial year following diagnosis, continuing, and last year of life) and tumor site for 13 cancers in men and 16 cancers in women through 2020. Cancer prevalence was calculated from cancer incidence and survival models estimated from Surveillance, Epidemiology, and End Results (SEER) Program data. Annualized net costs were estimated from recent SEER-Medicare linkage data, which included claims through 2006 among beneficiaries aged 65 years and older with a cancer diagnosis. Control subjects without can